Home Share Prices Stock Picker Financial Diary UK Indices UK Industry Sectors Company Lookup Share Risers Share Fallers Broker Ratings Finance Glossary SMS Services

Share Chat Finance News Blogs Live Prices Shares Bookshop Finance Tools Members

Round table discussion - PRECIOUS METALS

Latest Share Chat

SXX. It's cool no o-
ffense taken, I've ..

BLVN. (Business in
ameroon) - The Germ..

BLNX. http://techcr-
nch.com/2013/05/23/..

SCLP. http://www.bo-
tonglobe.com/busine..

BLVN. West Africa-f-
cused oil and gas e..

BLNX. .....still lo-
s making, unimpress..

GCM. legionnaire2
23 May'13 - 23:3..

FRR. Gosh early bir-
d you watching any..

RIA. up 13.51% on A-
SX @ 0.042,which co..

SRT. I was at the
swimming baths yes..

Astrazeneca Share Price (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price: 3,426.50

Bid: 3,427.50

Ask: 3,429.00

Change: 0.00 (0.00%)

Spread: 1.50

Spread as %: 0.04%

Open: 3,464.00

High: 3,465.00

Low: 3,411.00

Yesterday’s Close: 3,426.50

Get Live Streaming Prices for AZN - Click here to start your 7 day FREE trial today.

ASTRAZENECA PLC ORD SHS $0.25

Astrazeneca is listed in the FTSE 100, FTSE All-Share, FTSE 350
Astrazeneca is part of the Pharmaceuticals & Biotechnology sector

Intraday Astrazeneca Share Chart

Astrazeneca Share Price

Price

3426.50

Bid

3427.50

Ask

3429.00

Change

0.00%

0.00

Volume

3,028,074

Open

3,464.00

High

3,465.00

Low

3,411.00

3,426.50

Currency

GBX

3 Month Astrazeneca Share Graph

Currency	Issue Country	Shares in Issue	Market Capitalisation	Market Size
GBX	GB	1,249.69m	£42,820.66m	1,000

52 Week High	3,487.50	52 Week High Date	22-MAY-2013
52 Week Low	2,578.50	52 Week Low Date	1-JUN-2012

# Trades	Vol. Sold	Vol. Bought	PE Ratio	Earnings	Dividend	Yield
7,534	1,568,698	876,515	11.162	306.98	178.60	5.21

London South East Users info for Astrazeneca

Users who watch AZN also watch: Glaxosmithkline, Rio Tinto, Vodafone Grp., Barclays

Users who hold AZN also hold: Bp, Glaxosmithkline, Lloyds Grp., Vodafone Grp., Hsbc Hldgs.uk

Recent Share Trades for Astrazeneca (AZN)

Date

Time

Trade Prc

Volume

Buy/Sell

Bid

Ask

Value

23-May-13

16:40:09

3,436.7295

-501

Buy*

3,427.50

3,429.00

-17.22k

Trade Type:
Ordinary
Deletion

23-May-13

16:40:13

3,437.9369

2,450

Buy*

3,427.50

3,429.00

84.23k

Trade Type:
Ordinary
Deletion

23-May-13

16:40:13

3,438.2473

-1,949

Buy*

3,427.50

3,429.00

-67.01k

Trade Type:
Ordinary
Deletion

*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Astrazeneca trades >>

Trade Date	Action	Notifier	Price	Currency	Amount	Holding
Directors Deals for Astrazeneca (AZN)
07-May-13	Transfer From	Simon Lowth held the position of Interim CEO at AstraZeneca at the time of this trade. Simon Lowth	0		12,955	260877
29-Apr-13	Sell	Simon Lowth held the position of Interim CEO at AstraZeneca at the time of this trade. Simon Lowth	3328	GBX	8,690	0
26-Apr-13	Exercise of option	Simon Lowth held the position of Interim CEO at AstraZeneca at the time of this trade. Simon Lowth	2280	GBX	65,131	0

View more Astrazeneca directors dealings >>

Share Discussion for Astrazeneca (AZN)

Date/Time

Author

Subject

Share Price^†

Opinion

18 Apr '13

driftking27

dramatic rise overdone

3,342.50

Hold

Can any traders make it clear as to why this stock has rebounded around 20% since last year, when we know that patents are going over the cliff,, thus asles are dwindling away...? I own AZN, GSK, NVS[ Novartis ] & JNJ { Johnson & Johnson ]. I would be happy to invest more of my pennies in this just for the fact its a good dividend stock, and did have the biggest asles revenue for a EU pharma, which is pretty much changed and will do for the next 3years I believe. views!

1 Apr '13

driftking27

AZN

3,299.50

No Opinion

AZN has always outperformed GSK. AZN on the world scene is very much like Merck Inc. Here is more research for us investors. http://www.insidermonkey.com/blog/is-astrazeneca-plc-adr-nyseazn-going-to-burn-these-hedge-funds-102057/ The more the risk, the bigger the gains. What I can pass on is that the 200 Moving Daily Average is 2920p. This is the level to buy a lot more, and is what I will be doing with my next £8000. All the best with your investments. My best pharma at present is Novartis & JNJ.

1 Apr '13

driftking27

PHARMACEUTICAL SECTOR REVIEWED

3,299.50

Hold

Have a look át this technical analysis of TOP 10 pharmaceutical companies... http://m.seekingalpha.com/article/1311391

30 Mar '13

driftking27

AZN - future expiring patents...

3,299.50

Hold

http://www.advfn.com/nyse/StockNews.asp?stocknews=AZN&article=56075532 I will be buying a lot more on any dip this year. A dip for certain will happen after Q1 EPS in April. Profits will be hurt by expiring blockbuster drugs, and also a lack of gowth in key areas. I think AZN should downsize.

28 Mar '13

driftking27

AZN getting married...

3,297.00

Hold

http://www.fool.com/investing/general/2013/03/28/should-astrazeneca-and-bristol-myers-squibb-get.aspx

22 Mar '13

Deanowls

Correction

3,201.00

No Opinion

Clln, auto spellcheck!

^†Share prices shown are taken at time of message posting.

Thread View
View more share chat for Astrazeneca (AZN) >>

Please Login or Register to post messages

Request your Free brochures on share dealing, spread betting and CFDs

Website: ASTRAZENECA PLC ORD SHS $0.25
Website Description: AstraZeneca International - pharmaceutical company - prescription drugs - medicine manufacturers

Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.